Austin Moeller's questions to Cibus (CBUS) leadership • Q2 2025
Question
Austin Moeller from Canaccord Genuity Group Inc. asked about the next steps and potential hurdles in the EU's gene-editing approval negotiations, as communicated by Danish officials. He also requested an update on the current stage and evaluation timeline for the winter oilseed rape field trials in the UK.
Answer
Interim CEO Peter Beethen stated that the EU trialogue is progressing on key issues like labeling and patenting, with a final text expected within six months. CSO Greg Gochel added that the UK field trials are near the end of their second season, with harvest expected in August, and that results from the previous year were encouraging.